top of page

Plasma from recovered patients to treat COVID-19

Updated: Jun 28, 2020

 

Italy is facing a hard time with the new coronavirus outbreak, countries like India and the United Kingdom takes an uncompromising decision of locking down the whole country in a fight against the disease. India being the world's second-largest population, it would enthral the rest of the world to see the spectrum of 21 days lockdown.

Comparing COVID-19 with other diseases, it suggests that the new coronavirus is less deadly than the virus that caused outbreaks like SARS (severe acute respiratory syndrome), MERS (Middle East respiratory syndrome) and Ebola. However, the infection spreads more easily compared to other diseases. The basic reproduction number (R0) of the new coronavirus falls within the range of 2–2.5. Meanwhile, New York City follows China’s lead in treating COVID-19 patients with the plasma of people who have recovered from the disease. The drug Chloroquine and its derivative, hydroxychloroquine, are currently used for treating COVID-19 patients. Though it is generally considered safe and used for malaria or autoimmune diseases. Yet, upon its long-term usage, it can damage eyes, most common side-effect of the drug. However, the mechanism on how chloroquine works against the virus remains largely, hypothetical.


0 comments
bottom of page